INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 100 filers reported holding INARI MED INC in Q3 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $782,000 | – | 16,150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,298,217 | $200,611,000 | 20.83% |
| Pier Capital, LLC | 147,211 | $12,850,000 | 1.36% |
| Gyon Technologies Capital Management, LP | 28,956 | $2,528,000 | 0.87% |
| Lisanti Capital Growth, LLC | 66,201 | $5,779,000 | 0.80% |
| Intrinsic Edge Capital Management LLC | 116,242 | $10,147,000 | 0.75% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 181,803 | $15,870,000 | 0.71% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,035 | $2,011,000 | 0.63% |
| Perceptive Advisors | 668,500 | $58,353,000 | 0.63% |
| NEXT CENTURY GROWTH INVESTORS LLC | 68,563 | $5,984,000 | 0.50% |
| Affinity Asset Advisors, LLC | 10,000 | $873,000 | 0.46% |